Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BASICS-Kids: Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery
NCT06882772Phase 2Recruiting
- Sponsor
- University of Nebraska
- Start
- Nov 2026
- Primary completion
- Jun 2029
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of SunButyrate-TG in congenital heart disease (CHD), sponsored by University of Nebraska. Started Nov 2026; status: recruiting.
02
Drugs
SunButyrate-TG
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT06882772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06882772.